Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

Greasley, Samantha E.; Noell, Stephen; Plotnikova, Olga; Ferre, RoseAnn; Liu, Wei; Bolanos, Ben; Fennell, Kimberly; Nicki, Jennifer; Craig, Tim; Zhu, Yuao; Stewart, Al E.; Steppan, Claire M.

doi:10.1016/j.jbc.2022.101972

Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

Journal Article · 01 June 2022 · J. Biol. Chem.

DOI:https://doi.org/10.1016/j.jbc.2022.101972· OSTI ID:1871703

Greasley, Samantha E.; Noell, Stephen; Plotnikova, Olga; Ferre, RoseAnn; Liu, Wei; Bolanos, Ben; Fennell, Kimberly; Nicki, Jennifer; Craig, Tim; Zhu, Yuao; Stewart, Al E.; Steppan, Claire M.

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1871703

Journal Information:: J. Biol. Chem., Journal Name: J. Biol. Chem. Journal Issue: (6) Vol. 298

Country of Publication:: United States

Language:: ENGLISH

References (13)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern Vangeel, Laura; Chiu, Winston; De Jonghe, Steven Antiviral Research, Vol. 198 https://doi.org/10.1016/j.antiviral.2022.105252	journal	February 2022
On the use of the merging R factor as a quality indicator for X-ray data Weiss, M. S.; Hilgenfeld, R. Journal of Applied Crystallography, Vol. 30, Issue 2 https://doi.org/10.1107/S0021889897003907	journal	April 1997
Linking Crystallographic Model and Data Quality Karplus, P. A.; Diederichs, K. Science, Vol. 336, Issue 6084 https://doi.org/10.1126/science.1218231	journal	May 2012
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination Li, Pengfei; Wang, Yining; Lavrijsen, Marla Cell Research, Vol. 32, Issue 3 https://doi.org/10.1038/s41422-022-00618-w	journal	January 2022
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir Ullrich, Sven; Ekanayake, Kasuni B.; Otting, Gottfried Bioorganic & Medicinal Chemistry Letters, Vol. 62 https://doi.org/10.1016/j.bmcl.2022.128629	journal	April 2022
A pneumonia outbreak associated with a new coronavirus of probable bat origin Zhou, Peng; Yang, Xing-Lou; Wang, Xian-Guang Nature, Vol. 579, Issue 7798 https://doi.org/10.1038/s41586-020-2012-7	journal	February 2020
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition Sacco, Michael Dominic; Hu, Yanmei; Gongora, Maura Verenice Cell Research, Vol. 32, Issue 5 https://doi.org/10.1038/s41422-022-00640-y	journal	March 2022
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Gorbalenya, Alexander E.; Baker, Susan C. Nature Microbiology, Vol. 5, Issue 4, p. 536-544 https://doi.org/10.1038/s41564-020-0695-z	journal	March 2020
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19 Majumder, Joydeb; Minko, Tamara The AAPS Journal, Vol. 23, Issue 1 https://doi.org/10.1208/s12248-020-00532-2	journal	January 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 Boras, Britton; Jones, Rhys M.; Anson, Brandon J. Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-26239-2	journal	October 2021
An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 Owen, Dafydd R.; Allerton, Charlotte M. N.; Anderson, Annaliesa S. Science, Vol. 374, Issue 6575 https://doi.org/10.1126/science.abl4784	journal	December 2021
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients Su, Hai-xia; Yao, Sheng; Zhao, Wen-feng Acta Pharmacologica Sinica, Vol. 41, Issue 9 https://doi.org/10.1038/s41401-020-0483-6	journal	July 2020
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 Hoffman, Robert L.; Kania, Robert S.; Brothers, Mary A. Journal of Medicinal Chemistry, Vol. 63, Issue 21 https://doi.org/10.1021/acs.jmedchem.0c01063	journal	October 2020

Similar Records

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

Journal Article · 2021 · Nat. Microbio. · OSTI ID:1826782

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

Journal Article · 2021 · Cell Reports · OSTI ID:1981562

Characterization of an unusual SARS-CoV-2 main protease natural variant exhibiting resistance to nirmatrelvir and ensitrelvir

Journal Article · 2025 · Communications Biology · OSTI ID:2573349

Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

Citation Formats

References (13)

Similar Records

Related Subjects